Mimicking the human stratum corneum barrier: a biomimetic brick-and-mortar model for in vitro permeation study
Source abstract
Abstract
Abstract The development of reliable in vitro models for stratum corneum (SC) permeation studies remains a significant challenge. Ethical constraints, interspecies disparities, and inter-individual variability in skin underscore the need for standardized skin equivalents with significant research and commercial value. Conventional artificial skin models typically lack the characteristic ‘brick-and-mortar’ structure of the SC, the primary barrier of the skin, leading to measurable functional deviations from native tissue. To address this gap, we developed a biomimetic SC (ASC) that faithfully replicates the brick-and-mortar structure of the human SC. Polymer microspheres of a size mimicking corneocytes—composed of an optimized ternary polycaprolactone/poly(methyl methacrylate)/polyhydroxybutyrate blend—served as ‘bricks’ embedded within a lipid-based ‘mortar’ via a thermally assisted compression molding process. The resulting ASC demonstrated barrier properties comparable to those of excised human epidermis membrane (HEM). Permeability coefficients for five model drugs of diverse properties showed a Pearson’s correlation of r > 0.99 between ASC and HEM. Molecular simulations further elucidated the enhanced intermolecular interactions and restricted drug diffusion within the optimized polymer matrix. Furthermore, the ASC exhibited storage stability, maintaining consistent barrier properties over four weeks at −20 °C. This structurally biomimetic ASC represents a promising, predictive, and animal-free platform for in vitro permeation testing.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Wound Healing and Treatments · Inhalation and Respiratory Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Fine Chemicals, Department of Pharmaceutical Engineering, School of Chemical Engineering, Dalian University of Technology
National Institutes for Food and Drug Control, Department of Chemical Drugs, State Key Laboratory of Drug Regulatory Science
Funding
State Key Laboratory of Drug Regulatory Science Project · Key Research and Development Program of Liaoning Province
References (59)
Show source-provided references
1. Topical drug delivery: history, percutaneous absorption, and product development10.1016/j.addr.2021.113929 ↗
2. In vitro permeation testing for the evaluation of drug delivery to the skin10.1016/j.ejps.2024.106873 ↗
3. In vitro permeation test (IVPT) for pharmacokinetic assessment of topical dermatological formulations10.1002/cpph.79 ↗
4. Human epidermal in vitro permeation test (IVPT) analyses of alcohols and steroids10.1016/j.ijpharm.2022.122114 ↗
5. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption10.1016/S0378-5173(00)00665-7 ↗
6. Reconstructed human epidermis: an alternative approach for in vitro bioequivalence testing of topical products10.3390/pharmaceutics14081554 ↗
7. Use of PBPK modelling to extrapolate in vitro porcine ear skin permeability to in vivo human dermal absorption10.1016/j.ijpharm.2025.126168 ↗
8. Recent developments in skin mimic systems to predict transdermal permeation10.2174/1381612821666150428124733 ↗
9. Development of phospholipid vesicle-based permeation assay models capable of evaluating percutaneous penetration enhancing effect10.1080/03639045.2017.1371730 ↗
10. Human skin equivalents: impaired barrier function in relation to the lipid and protein properties of the stratum corneum10.1016/j.addr.2021.05.012 ↗
11. Permeability of the reconstructed human epidermis model Episkin® in comparison to various human skin preparations10.1016/j.ejpb.2006.08.012 ↗
12. Reduced cytotoxicity and enhanced bioactivity of cationic antimicrobial peptides liposomes in cell cultures and 3D epidermis model against HSV10.1016/j.jconrel.2016.03.025 ↗
13. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers10.1038/nprot.2007.303 ↗
14. Different immortalized keratinocyte cell lines display distinct capabilities to differentiate and reconstitute an epidermis in vitro10.1111/exd.14985 ↗
15. Unravelling effects of relative humidity on lipid barrier formation in human skin equivalents10.1007/s00403-019-01948-3 ↗
16. Strat-M® positioning for skin permeation studies: a comparative study including EpiSkin® RHE, and human skin10.1016/j.ijpharm.2023.123488 ↗
17. Strat-M® synthetic membrane: permeability comparison to human cadaver skin10.1016/j.ijpharm.2018.06.012 ↗
18. Suitability of skin-PAMPA and chromatographic systems to emulate skin permeation. Influence of pH on skin-PAMPA permeability10.1016/j.microc.2023.108567 ↗
19. Skin–PAMPA: a new method for fast prediction of skin penetration10.1016/j.ejps.2012.01.011 ↗
20. Lipid-coated membranes as skin surrogates for permeability assessment10.1016/j.mtla.2022.101354 ↗
21. Development of a novel human stratum corneum model, as a tool in the optimization of drug formulations10.1016/j.ijpharm.2019.118571 ↗
22. Development of a novel human stratum corneum mimetic phospholipid -vesicle-based permeation assay models for in vitro permeation studies10.1080/03639045.2024.2331242 ↗
23. Bricks and mortar of the epidermal barrier10.1038/emm.1999.2 ↗
24. Uptake and desorption of hydrophilic compounds from human stratum corneum10.1016/j.jconrel.2017.06.015 ↗
25. The skin barrier: an extraordinary interface with an exceptional lipid organization10.1016/j.plipres.2023.101252 ↗
26. Human skin surface lipid film: an ultrastructural study and interaction with corneocytes and intercellular lipid lamellae of the stratum corneum10.1046/j.1365-2133.1999.02697.x ↗
27. A comparative analysis of biological and synthetic skin models for drug transport studies10.1007/s11095-023-03499-9 ↗
28. Validation and testing of a new artificial biomimetic barrier for estimation of transdermal drug absorption10.1016/j.ijpharm.2022.122266 ↗
29. The development of an artificial skin membrane mimicking the lipid bilayer structure for in vitro permeation study10.1016/j.colsurfa.2022.128609 ↗
30. Permeation kinetics of active drugs through lanolin-based artificial membranes10.1016/j.colsurfb.2020.111024 ↗
31. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: from liposomal preparation to therapy10.1016/j.ijpharm.2018.09.047 ↗
32. Regional differences of cell sizes in the human stratum corneum. Part I10.1111/1523-1747.ep12551482 ↗
33. A novel in vitro percutaneous penetration model: evaluation of barrier properties with p-aminobenzoic acid and two of its derivatives10.1007/s11095-006-9909-1 ↗
34. Analysis of in vitro drug dissolution from PCL melt extrusion10.1016/j.cej.2010.03.077 ↗
35. Comparison of modern in vitro permeability methods with the aim of investigation nasal dosage forms10.3390/pharmaceutics13060846 ↗
36. A combined experimental and in silico approach to determine the compatibility of poly(ester amide)s and indomethacin in polymer nanoparticles10.1016/j.eurpolymj.2021.110606 ↗
37. Beware of the flory parameter to characterize polymer-polymer interactions: a critical reexamination of the experimental literature10.1016/j.eurpolymj.2016.09.009 ↗
38. Influence of cryopreservation methods of ex vivo rat and pig skin on the results of in vitro permeation test10.1016/j.ejpb.2023.06.004 ↗
39. A multiphase microscopic diffusion model for stratum corneum permeability. II. Estimation of physicochemical parameters, and application to a large permeability database10.1002/jps.20883 ↗
40. Use of “bricks and mortar” model to predict transdermal permeation: model development and initial validation10.1021/ie701711v ↗
41. Modeling transdermal permeation. part I. Predicting skin permeability of both hydrophobic and hydrophilic solutes10.1002/aic.12048 ↗
42. Recent advances in predicting skin permeability of hydrophilic solutes10.1016/j.addr.2012.05.001 ↗
43. Modeling transdermal permeation. part 2. Predicting the dermatopharmacokinetics of percutaneous solute10.1002/aic.12146 ↗
44. A multiphase microscopic diffusion model for stratum corneum permeability. I. Formulation, solution, and illustrative results for representative compounds10.1002/jps.20509 ↗
45. Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism10.1021/js960198e ↗
46. In-silico model of skin penetration based on experimentally determined input parameters. Part I: experimental determination of partition and diffusion coefficients10.1016/j.ejpb.2007.05.012 ↗
47. In-silico model of skin penetration based on experimentally determined input parameters. Part II: mathematical modelling of in-vitro diffusion experiments. Identification of critical input parameters10.1016/j.ejpb.2007.05.018 ↗
48. Effect of stratum corneum heterogeneity, anisotropy, asymmetry and follicular pathway on transdermal penetration10.1016/j.jconrel.2017.05.034 ↗
49. Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides10.1016/j.plipres.2016.04.001 ↗
50. Simultaneous measurements of structure and water permeability in an isolated human skin stratum corneum sheet10.3390/polym11050829 ↗
51. The enantioselective enhancing effect and mechanistic insights of chiral enhancers in transdermal drug delivery10.1016/j.ajps.2023.100849 ↗
52. The influence of various freezing–thawing methods of skin on drug permeation and skin barrier function10.1208/s12248-024-00941-7 ↗
53. Prediction of skin permeation by chemical compounds using the artificial membrane, Strat-M™10.1016/j.ejps.2014.11.002 ↗
54. Double-layer skin equivalents as diffusion models for topical and transdermal drug delivery studies10.1016/j.carbpol.2025.123446 ↗
55. A biomimetic multifunctional dressing based on stratum corneum microstructure: integrating antibacterial barrier and breathability for enhanced wound healing10.1016/j.biomaterials.2025.123639 ↗
56. Transdermal and lateral effective diffusivities for drug transport in stratum corneum from a microscopic anisotropic diffusion model10.1016/j.ejpb.2023.01.025 ↗
57. Are lateral lipid-phase diffusion coefficients pertinent to dermal absorption?10.1016/j.jconrel.2025.113773 ↗
58. Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review10.1016/j.tiv.2008.10.008 ↗
59. Measuring the stratum corneum reservoir: desorption kinetics from keratin10.1002/jps.23245 ↗